Trans-China Automotive Holdings Limited (SGX:VI2)
Singapore · Delayed Price · Currency is SGD 0.0390
0.00 (0.00%)
At close: Aug 12, 2025
Intra-Cellular Therapies Market Cap
SGXC:VI2 has a market cap or net worth of 22.99 million as of August 12, 2025. Its market cap has decreased by -22.00% in one year.
Market Cap
22.99M
Enterprise Value
125.13M
Revenue
477.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since November 11, 2021, SGXC:VI2's market cap has decreased from 143.16M to 22.99M, a decrease of -83.94%. That is a compound annual growth rate of -38.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 22.99M | -25.00% |
| Dec 31, 2024 | 30.66M | -52.73% |
| Dec 29, 2023 | 64.86M | -37.85% |
| Dec 30, 2022 | 104.36M | -33.85% |
| Dec 31, 2021 | 157.77M | 10.20% |
| Nov 11, 2021 | 143.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBS Group Holdings | 144.00B |
| Oversea-Chinese Banking Corporation | 75.86B |
| Singapore Telecommunications | 64.73B |
| United Overseas Bank | 59.55B |
| Singapore Technologies Engineering | 26.91B |
| Jardine Matheson Holdings | 20.88B |
| Singapore Airlines | 19.70B |
| Wilmar International | 18.54B |